121 related articles for article (PubMed ID: 28260015)
1. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas.
Rai A; Das L; Mukherjee KK; Dhandapani S; Tripathi M; Ahuja CK; Radotra BD; Dutta P
Front Endocrinol (Lausanne); 2021; 12():708111. PubMed ID: 34295309
[TBL] [Abstract][Full Text] [Related]
3. Non-functioning pituitary adenomas: growth and aggressiveness.
Øystese KA; Evang JA; Bollerslev J
Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
[TBL] [Abstract][Full Text] [Related]
5. Non-functioning pituitary adenoma: immunohistochemical analysis of 85 cases.
Mahta A; Haghpanah V; Lashkari A; Heshmat R; Larijani B; Tavangar SM
Folia Neuropathol; 2007; 45(2):72-7. PubMed ID: 17594597
[TBL] [Abstract][Full Text] [Related]
6. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance.
Chen W; Wang M; Duan C; Yao S; Jiao H; Wang Z; Hu B; Mao Z; Zhu Y; Wang H
Front Endocrinol (Lausanne); 2021; 12():748997. PubMed ID: 34659129
[TBL] [Abstract][Full Text] [Related]
8. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
9. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of E-cadherin and β-catenins in pituitary adenoma.
Zhou K; Jin H; Luo Y
Int J Surg Pathol; 2013 Aug; 21(4):363-7. PubMed ID: 23349466
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of EpCAM and Trop2 in pituitary adenomas.
Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
[TBL] [Abstract][Full Text] [Related]
13. [Morphofunctional features of non-functioning pituitary adenomas].
Eremkina AK; Dzeranova LK; Pigarova EK; Mokrysheva NG; Dedov II
Arkh Patol; 2019; 81(1):71-78. PubMed ID: 30830109
[TBL] [Abstract][Full Text] [Related]
14. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract][Full Text] [Related]
15. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
16. Low expression of secreted frizzled-related protein 2 and nuclear accumulation of β-catenin in aggressive nonfunctioning pituitary adenoma.
Wu Y; Bai J; Hong L; Liu C; Yu S; Yu G; Zhang Y
Oncol Lett; 2016 Jul; 12(1):199-206. PubMed ID: 27347125
[TBL] [Abstract][Full Text] [Related]
17. FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas.
Hanson PL; Aylwin SJ; Monson JP; Burrin JM
Eur J Endocrinol; 2005 Mar; 152(3):363-70. PubMed ID: 15757852
[TBL] [Abstract][Full Text] [Related]
18. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts play a potential role in bone destruction via osteopontin related caldesmon expression and polymerization in human non-functioning pituitary adenomas.
Zhang LY; Ge XL; Li Z; Tang YJ; Xiong YY; Li XJ; Liu JF; Wanggou SY; Li CT; Yang K; Chen X; Hu ZL; Liu YS; Liu ZX
Sci Rep; 2017 Dec; 7(1):17523. PubMed ID: 29235490
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
Gu YH; Feng YG
J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
